The metabolic syndrome is a predictor of type II diabetes mellitus and cardiovascular disease. The mechanisms of the increased blood pressure (BP) in patients with the metabolic syndrome are poorly understood. We investigated if salt-sensitivity is a characteristic of the metabolic syndrome. A total of 301 subjects (87male subjects, 214 female subjects) of 41.570.7 years of age completed a salt sensitivity test, and were evaluated for the presence of metabolic syndrome. BP and 24-h sodium excretion were obtained under usual, high-and low-salt intakes. BP reactivity to salt was markedly increased in subjects with the metabolic syndrome; its magnitude was directly related to the severity of the syndrome. Reducing dietary salt from the average usual intake (8.2 g/day) to nearly 2.3 g/day lowered systolic blood pressure (SBP) by 8.771.3 mm Hg in subjects with four and five traits, 6.071.1 in those with three traits and failed to modify the BP of subjects with one or no traits of the syndrome (Po0.0001). Salt restriction reduced the percentage of subjects with metabolic syndrome that were hypertensive (8.2 g/day of salt) from 23.8 to 8.2% (v 2 : 23.6; Po0.0001). BP of non-hypertensive subjects with metabolic syndrome was also significantly reduced by salt restriction (7.171.5 and 4.271.1 mm Hg in those with four or five traits and three traits, respectively). In conclusion, the metabolic syndrome is a strong clinical predictor of salt sensitivity. The enhanced BP reactivity to dietary salt observed in subjects with the metabolic syndrome, may determine the increased BP levels commonly associated with the syndrome.
Introduction
The metabolic syndrome is a highly prevalent condition characterized by a cluster of risk factors, and is associated with the development of type II diabetes and cardiovascular disease. [1] [2] [3] [4] [5] Central obesity, reduced high-density lipoprotein (HDL) cholesterol, increased triglycerides, high blood pressure (BP) and abnormal glucose metabolism 6 are among the traits used in defining the syndrome. The mechanisms underlying the increase in BP associated with the metabolic syndrome are poorly understood, and are addressed in this study.
The BP reactivity to salt, also known as salt sensitivity varies considerably between individuals. [7] [8] [9] Exaggerated BP reactivity to salt, known as salt sensitivity, is associated with increased risk for cardiovascular events. [10] [11] [12] [13] [14] Although genetic and acquired factors play a role in the pathogenesis of salt sensitivity, its aetiology is unknown. Older age and insulin resistance have been reported to be associated with salt sensitivity. 7, 8, [15] [16] [17] [18] [19] As insulin resistance is the landmark of the metabolic syndrome, 20, 21 we proposed that salt sensitivity is more prevalent in subjects with than in subjects without the syndrome. To test our hypothesis, salt sensitivity testing was used to compare the BP reactivity to salt of subjects with and without the metabolic syndrome. If our hypothesis is correct, salt restriction could be an integral part of the treatment for patients with the metabolic syndrome.
Materials and methods

Study population
Voluntary subjects of 18-70 years of age, living in the city of Caracas, and attending the Center for the Detection and Treatment of Silent Risk Factors for Cardiovascular and Metabolic Diseases, from 1999 to 2004 were evaluated and screened for study enrolment.
Advertisement of Center activities and subject recruitment was achieved by health practitioners' referral and by an integrated programme of educational activities, radio announcements, flyers, health fairs, and health, hypertension and diabetes screening days. Patients were excluded if they were older than 70 years, or if they had a history of coronary artery disease, heart failure, valvular heart disease, stroke, transient ischaemic attacks, arteriosclerosis obliterans, renal or hepatic dysfunction, active inflammatory disease states, severe hypertension, oral contraceptive use and serum creatinine concentration 42 mg/dl. A complete history, physical examination and laboratory work-up, including haematology, chemistry, lipid panel, oral glucose tolerance test, liver function tests and urinalysis, were obtained. Only nine subjects were on antihypertensive monotherapy and three on statins. Medications were gradually discontinued over 2 weeks. Lipid-lowering medications were withheld for 4 weeks and antihypertensive drugs for 8 weeks before the salt sensitivity testing. Upon completion of the test, patients reinitiated their drug treatment. BP was monitored on a weekly basis after antihypertensive drug withdrawal. The research protocol was approved by the Central University Hospital of the city of Caracas, and by the Nova Southeastern University Review Boards. All participants gave written informed consent.
Diagnosis of metabolic syndrome was made following the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of the High Blood Cholesterol in Adults (ATPIII) guidelines: waist circumference: men 4102 cm (440 inch), women: 488 cm (35 inch); triglycerides X150 mg/dl (X1.7 mmol/l), HDL-cholesterol: men o40 mg/dl (o1.03 mmol/l), women o50 mg/dl (X1.29 mmol/l), BP X130/ X85 mm Hg and fasting glucose X110 mg/dl (X6.1 mmol/l) 6 . Owing to the young age of our study population, only eight subjects had five traits of the metabolic syndrome; therefore, subjects with four and five traits were combined as a group.
Procedures
Salt sensitivity testing was conducted in all subjects by measuring the BP during usual (baseline BP), high-and low-salt diets. Baseline BP readings were obtained just before the initiation of the salt sensitivity testing once the first 24 h urine collection sample was provided. Subsequently, subjects were instructed to continue with their dietary habits and to take daily 10 1 g tablets of sodium chloride for 1 week (B18 g/day). The high-salt period was followed by a 1-week period of low-salt diet designed to provide nearly 2.5 g/day. At the end of each period, patients completed 24-h urine collections, and returned for BP and heart rate measurements.
The 24-h urinary sodium excretion was used to determine actual levels of salt intake and compliance with sodium diets. 22 All subjects, with and without the metabolic syndrome, were exposed to the same order of salt diets: first usual, next high-and last low-salt intake. This order was chosen AS it better tests for the BP effects of salt restriction than for the effects of high salt. However, the design does not rule out an, although unlikely, order effect of diets.
BP was measured with a standard mercury sphygmomanometer, and the cuff size was optimized for arm circumference. The same cuff and sphygmomanometer was used to measure the BP in a specific patient. BP was obtained after 30 min rest in the supine position. Because BP was the main variable of the study, resting BP was best attained with patients lying comfortably rather than sitting for 30 min. The average of three consecutive BP readings not greater than 4 mm Hg apart from each other was used. During the salt sensitivity testing, the investigators obtaining the BP readings were not aware of the salt intake of the study subjects, nor of the subjects' BP at baseline. Results were provided to the study assistant who entered the BP data in the subject's data collection form. Heart rate was estimated from a 1-min pulse. Waist and hip circumferences were measured at the level of the umbilicus and at the broadest level of the trocanteric region, respectively. Body mass index (BMI) was calculated as body weight in kg/height in metres squared (kg/m 2 ).
Statistical analyses
Descriptive statistics were generated for the study population using means (and s.e.m.) for continuous variables and proportions for dichotomous variables. Two-sample comparison for continuous variables was analysed with the Student's t-test. Multiple sample comparison for continuous variables was performed by one-way analysis of variance (ANOVA), followed by post hoc analysis by means of the Tukey's multiple comparisons test. Triglyceride and insulin concentrations were logtransformed for statistical analysis and back-transformed for reporting. Proportions were compared by w 2 analysis. Pearson correlation analysis was used to assess the relationships between continuous variables. One-way analysis of covariance and linear stepwise regression were used to adjust for confounding factors. All probability tests were twosided. Differences were considered significant at values of Po0.05. All statistical analysis was performed with SPSS version 11.0 (SPSS Inc., Chicago, IL, USA).
Results
A total of 301 subjects (87 male subjects, 214 female subjects) of 41.570.7 years of age were studied.
The ethnic distribution were as follows: 25% whites, 2% Mulattos and 73% mixed Hispanics. Thirty-seven had BP X140/90 mm Hg. All subjects completed the salt sensitivity testing. For the 301 subjects, systolic blood pressure (SBP) at usual salt intake (13773 mmoles of sodium/day, B8 g/salt) averaged 11970.9 mm Hg. During the high-salt period (30577 mmoles of sodium/day, B18 g/salt), SBP averaged 12270.9 mm Hg, and it was reduced to 11570.7 mm Hg with the low-sodium diet (4072 mmoles of urinary sodium/day, B2.3 g/salt). The reduction in SBP induced by salt restriction was comparable in men and women (6.970.8 mm Hg in men and 7.470.7 mm Hg in women; P40.5). The magnitude of BP reduction, a measure of salt sensitivity, was found directly related to age (r ¼ 0.3) (Po0.0001) and to the baseline BP (r ¼ 0.39) (Po0.0001). Although significant, lesser degrees of association were found with waist (r ¼ 0.15; P ¼ 0.007) and BMI (r ¼ 0.14; P ¼ 0.02). Weight, fasting or 2-h post-load glucose and insulin levels, HDL-cholesterol and triglycerides did not significantly correlate with salt sensitivity. Baseline SBP (P ¼ 0.009) and diastolic blood pressure (DBP) (Po0.01) remained significantly associated with BP reactivity to salt after factoring for age, BMI and waist as covariates.
Of the 301 subjects, 109 (34%) met the NCEP-ATPIII criteria for the metabolic syndrome. As expected, subjects with the metabolic syndrome were older, heavier, had larger waist circumference, higher BP, resting heart rates, triglycerides, glucose and insulin levels, and lower HDL-cholesterol levels than those without the metabolic syndrome ( Table 1 ). The magnitude of each of the traits increased in parallel with the number of traits. Subjects with more severe syndrome had not only more traits present (i.e., four to five traits) but were also heavier, had larger waists, higher triglycerides, BP, glucose and insulin levels, and lower HDL than subjects with lesser number of traits.
Although both the groups excreted comparable amounts of sodium on high-and low-sodium diets, salt restriction produced greater BP lowering in subjects with than in subjects without the metabolic syndrome (Table 2 and Figure 1 ). The degree of salt sensitivity was directly related to the severity of the metabolic syndrome, and was independent of the gender (Figure 2 ). Reducing salt intake from high to low (18-2.3 g/day) decreased the SBP by 12.671.2 mm Hg in subjects with more severe metabolic syndrome. Importantly, subjects with only two traits, not meeting criteria for the metabolic syndrome, were already more reactive to salt than subjects free of traits (Po0.01) (Figure 2 ). The greater BP reactivity to salt of subjects meeting the ATPIII criteria for the metabolic syndrome, was also present if hypertensive patients (X140/90 mm Hg at baseline) were excluded from the analysis. In nonhypertensive individuals, reducing salt intake from high to low lowered SBP by 11.671.5, 6.771.2 and by 3.771.1 mm Hg, in those with four and five traits, two traits or no traits, respectively.
As salt intake during the high-salt period was higher than the subjects' usual salt intake, we assessed whether the increased reactivity to salt could also increase BP at usual salt intake (8.2 g/day) (Figure1 and Table 3 ). Lowering salt intake from usual (8.2 g) to 2.3 g/day (low-salt diet) decreased Shown are the means7s.e.m. for the BP changes induced by salt restriction in mm Hg and for the absolute levels of urinary sodium in mmoles/day, in subjects with and without the metabolic syndrome. During salt sensitivity testing, subjects were first exposed to a week of a high-salt diet followed by a week of a low-salt diet. BP and urinary sodium were obtained at the end of both weeks. BP changes (DSBP and DDBP) were calculated as follows: BP on high salt minus BP on low salt. Minus signs indicate BP reduction. Significant differences at *Po0.05, **Po0.01.
SBP by 8.771.3 mm Hg in subjects with four or five traits, by 3.470.8 mm Hg in those with two traits and by 1.070.9 in subjects with one or no traits of the metabolic syndrome (Table 3 ). In patients meeting criteria for the metabolic syndrome, salt restriction also reduced the prevalence of hypertension (X140/90 mm Hg) from 23.8 to 8.2% (w 2 : 23.6; Po0.0001). In addition, in non-hypertensive individuals with four or five traits, three traits and two traits, reducing salt intake from usual to low decreased SBP by 7.171.5, 4.271.1 and 1.871 mm Hg, respectively.
As subjects with the metabolic syndrome were on average 5 years older than those without the syndrome, we explored whether the age difference determined the increase in salt sensitivity associated with the metabolic syndrome. An analysis was performed in subjects aged 40-60 years (n ¼ 157). The average age for those without the syndrome was 48.870.5 years (n ¼ 95) and 49.370.6 years for subjects with the syndrome (n ¼ 62) (Po0.1). Despite their comparable ages, salt restriction lowered SBP/DBP by 11.371.1/5.170.5 mm Hg in those with the syndrome, and by 6.870.9/ 2.970.6 mm Hg in those without the syndrome (Po0.01).
Discussion
In this study, we demonstrated that the BP of subjects with the metabolic syndrome is exquisitely sensitive to dietary salt. Decreasing usual daily salt intake from an average of 8-2.3 g lowered SBP by 9 mm Hg in individuals with four and five traits of the syndrome, and reduced the percentage of subjects with the metabolic syndrome that had BP in the hypertensive range from 23.8 to 8.2%. Importantly, the greater BP reactivity to salt associated with the metabolic syndrome was also observed if hypertensive individuals were excluded from the analysis. Our findings suggest that due to increased salt sensitivity, dietary salt increases the BP of subjects with the metabolic syndrome. We propose that dietary salt is a major determinant of the increased BP associated with the metabolic syndrome.
The coexistence of traits present and the magnitude of a given trait describe the severity of the metabolic syndrome. In our subjects, the degree of salt sensitivity was found directly related to the severity of the metabolic syndrome. Salt restriction induced greater BP lowering in subjects with more advanced syndrome. Our work indicates that the Effects of three different levels of salt intake on SBP in subjects with and without the metabolic syndrome. Shown are the mean values7s.e.m. for the SBP obtained during usual (8.2 g of salt/day, 137 mmoles/sodium), high (18 g of salt/day, 300 mmoles/ day of sodium) and a low-salt diet (2.4 g of salt/day, 40 mmoles/ day of sodium) in subjects with the metabolic syndrome (MS) and without the syndrome (no MS). Statistical significances were assessed by one-way ANOVA followed by Tukey's test. Significantly different from low-sodium diet at *Po0.01. Figure 2 Relationships between the number of traits of the metabolic syndrome and salt sensitivity. Subjects underwent salt sensitivity testing. They were first exposed to a high-salt diet (18 g/day salt, 300 mmoles/day of sodium) for 1 week, followed by a low-salt diet (2.3 g salt/day, 40 mmoles/day of sodium) for an additional week. Low salt-induced BP lowering was calculated as follows: BP on high salt minus BP on low salt. (a) Depicts decreases in SBP and DBP for all patients. (b) Depicts the decreases in SBP for men and women separately. Shown are the mean values7s.e.m. for the reduction in BP induced by salt restriction. Statistical significances were assessed by one-way ANOVA followed by Tukey's test. Significant differences between subjects with four and five traits and other groups at *Po0.05 and **Po0.01.
increased BP reactivity to salt is not an all or none phenomenon, but rather a gradual condition that develops and worsens in parallel with the duration and severity of the syndrome. Individuals in whom more traits coexist have a greater BP reactivity to salt. Interestingly, subjects with two traits, even though failed to meet the NCEP ATPIII criteria for the metabolic syndrome, were already more salt sensitive than those with one or no traits. These results are not surprising as presence of two risk factors has been associated with increased risk for mortality from congestive heart failure and cardiovascular disease. 23 In addition, individuals with two traits of the metabolic syndrome have greater waist circumferences and greater insulin responses to an oral glucose load than those with one or no traits (Hoffmann and Cubeddu, unpublished observations). Older age 7, 8 and African-American ethnicity [7] [8] [9] have been linked to salt sensitivity. However, the similar ethnic ancestry and racial characteristics of subjects with and without the metabolic syndrome is against a possible role of ethnicity in determining the increase in salt sensitivity associated with the metabolic syndrome. Similarly, the role of older age is also quite unlikely. As expected for the natural course of the syndrome, subjects with the metabolic syndrome were older than those without the syndrome; however, those with the metabolic syndrome were only an average of 5 years older than those without the syndrome. In addition, most of our study patients were young and middle-aged adults, not elderly individuals; and finally, a subgroup analysis of subjects aged 40-60 years, demonstrated that despite the comparable age of both groups, those with the metabolic syndrome were more salt sensitive than those without the syndrome.
Observations in animal models indicate that saltsensitive animals develop high BP only in the presence of dietary salt. 24 These observations support the view that the increases in BP that cluster with traits of the metabolic syndrome largely results from dietary salt owing to increased salt sensitivity. Therefore, if the BP were not increased by dietary salt, restricting salt intake would not lower the BP, whereas when baseline BP is increased by dietary salt, large BP drops are observed with low-salt diets. These findings account for the strong association observed between salt sensitivity and baseline BP. Although the pathogenesis of the salt-sensitivity associated with the metabolic syndrome is unknown, it may result from endothelial dysfunction and vascular inflammation present in subjects with the syndrome. [25] [26] [27] [28] Further studies are in progress to explore these possibilities.
How much salt restriction is needed to achieve BP control in subjects with the metabolic syndrome has not been established. In this study, 2.3 g of salt/day was very effective in lowering BP in subjects with the syndrome. A meta-analysis of population salt studies indicates that the magnitude of the BP reduction is related to the degree of the salt reduction, and that the lower the salt intake achieved, the lower the BP. 29 The BP-lowering efficacy of more moderate salt restriction in subjects with metabolic syndrome has not been explored. Additionally, we do not know whether the BP effects of salt restriction are sustained, as only short-term effects of low salt were studied.
Although the metabolic syndrome is easily recognized in clinical practice, salt sensitivity is not. Testing for salt sensitivity is cumbersome and thus restricted to research protocols. Therefore, predictors of salt sensitivity are needed to individualize, as well as to reinforce the indication for salt restriction. In clinical practice, salt restriction forms part of the general life-style modifications in the treatment of high BP. 30 Salt restriction is prescribed for high BP not knowing whether patients would respond (salt sensitive) or not (salt resistant) to it. Our observation that the metabolic syndrome is a strong clinical predictor of salt sensitivity provides evidence in favour of prescribing salt restriction (in combination with weight loss and physical activity) for the management of patients with this condition. Prospective long-term interventional studies are needed to confirm our observation. Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure. Shown are the means7s.e.m. for the BP changes induced by salt restriction, and for the absolute levels of SBP at the two levels of salt intake in subjects with different number of traits. Control subjects had no traits of the metabolic syndrome. Data from subjects with four and five traits were combined. BP changes (DSBP and DDBP) were calculated as follows: BP on usual dietary salt intake minus BP on low salt. One-way ANOVA was followed by the Tukey's multiple comparisons test. Significant differences from 4+5 traits at *Po0.05, **Po0.01
In conclusion, the metabolic syndrome is a major health problem known to increase the risk of cardiovascular events and of type II diabetes mellitus. [1] [2] [3] [4] [5] Increased BP is one of the contributory traits to the syndrome; however, the mechanism of the increase in BP observed in obese high-risk subjects is unclear. In this study, we report an increased prevalence of salt sensitivity in subjects with the metabolic syndrome, and that a large part of the increase in BP associated with the cluster of traits defined as metabolic syndrome results from dietary salt. The reported increase in salt sensitivity was found directly related to the severity of each trait and to the number of traits that coexist in an individual.
